Medicare Part B | Citizens Against Government Waste

Medicare Part B

GAO: PBMs Gave Back Majority of Drug Rebates

PBMs provide a valuable service in delivering drug benefits to beneficiaries.

August 15, 2019 — Elizabeth Wright 1565896428

Binding Arbitration for Medicare Part B: Price Controls by Another Name

The Trump administration proposed using an International Pricing Index in October 2018 to reimburse providers for drugs administered under Medicare Part B.  These drugs require the involvement of a physician and include, but are not limited to, infused and injectable drugs, some antigens, drugs used with durable medical equipment, and blood clotting factors.  Instead of reimbursing the provider of Part B d

April 24, 2019 — Elizabeth Wright 1556119688

Adopting Foreign Countries’ Price Controls: A Really Bad Idea

Citizens Against Government Waste (CAGW) was troubled and mystified when the Trump administration issued an advanced notice of proposed rulemaking that would change Medicare Part B reimbursement for outpatient drugs from the Average Sales Price (ASP) plus 6 percent to instead a reimbursement system based on what other countries pay for the same drugs.

October 31, 2018 — Elizabeth Wright 1541012883

Taxpayers and Patients Win Second Round on 340B Drug Discount Rule

In January, Citizens Against Government Waste (CAGW) discussed a court case concerning a November 1, 2017 Centers for Medicare and Medicaid Services (CMS) final rule for Medicare Part B that will lower costs to taxpayers and Medicare beneficiaries for certain outpatient pharmaceuticals purchased under the 340B drug discount program.  It is expected the rule will save Medicare beneficiarie

July 18, 2018 — Elizabeth Wright 1531943166

Taxpayers and Patients Win First Round on 340B Drug Discount Rule

Citizens Against Government Waste (CAGW) discussed in its November 7, 2017 WasteWatcher blog, a Centers for Medicare and Medicaid Services (CMS) final rule for Medicare Part B that will lower costs to taxpayers and Medicare beneficiaries for certain outpatient pharmaceuticals purchased under the 340B drug discount program.

January 5, 2018 — Elizabeth Wright 1515168255

Sign Up For Email Updates


Optional Member Code